Literature DB >> 22354031

Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host.

Zachary P Weiner1, Ian J Glomski.   

Abstract

Since 1957, it has been proposed that the dissemination of inhalational anthrax required spores to be transported from the lumena of the lungs into the lymphatic system. In 2002, this idea was expanded to state that alveolar macrophages act as a "Trojan horse" capable of transporting spores across the lung epithelium into draining mediastinal lymph nodes. Since then, the Trojan horse model of dissemination has become the most widely cited model of inhalational infection as well as the focus of the majority of studies aiming to understand events initiating inhalational anthrax infections. However, recent observations derived from animal models of Bacillus anthracis infection are inconsistent with aspects of the Trojan horse model and imply that bacterial dissemination patterns during inhalational infection may be more similar to the cutaneous and gastrointestinal forms than previously thought. In light of these studies, it is of significant importance to reassess the mechanisms of inhalational anthrax dissemination, since it is this form of anthrax that is most lethal and of greatest concern when B. anthracis is weaponized. Here we propose a new "jailbreak" model of B. anthracis dissemination which applies to the dissemination of all common manifestations of the disease anthrax. The proposed model impacts the field by deemphasizing the role of host cells as conduits for dissemination and increasing the role of phagocytes as central players in innate defenses, while moving the focus toward interactions between B. anthracis and lymphoid and epithelial tissues.

Entities:  

Mesh:

Year:  2012        PMID: 22354031      PMCID: PMC3347428          DOI: 10.1128/IAI.06061-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  72 in total

1.  Prevention of inhalational anthrax in the U.S. outbreak.

Authors:  Ron Brookmeyer; Natalie Blades
Journal:  Science       Date:  2002-03-08       Impact factor: 47.728

2.  The respiratory retention of bacterial aerosols: experiments with radioactive spores.

Authors:  G J HARPER; J D MORTON
Journal:  J Hyg (Lond)       Date:  1953-09

3.  Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores.

Authors:  H A DRUETT; D W HENDERSON; L PACKMAN; S PEACOCK
Journal:  J Hyg (Lond)       Date:  1953-09

4.  Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.

Authors:  Aaron M Firoved; Georgina F Miller; Mahtab Moayeri; Rahul Kakkar; Yuequan Shen; Jason F Wiggins; Elizabeth M McNally; Wei-Jen Tang; Stephen H Leppla
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

5.  Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan.

Authors:  Thomas Candela; Agnès Fouet
Journal:  Mol Microbiol       Date:  2005-08       Impact factor: 3.501

6.  Difference between the spore sizes of Bacillus anthracis and other Bacillus species.

Authors:  M Carrera; R O Zandomeni; J Fitzgibbon; J-L Sagripanti
Journal:  J Appl Microbiol       Date:  2007-02       Impact factor: 3.772

7.  The protective antigen component of anthrax toxin forms functional octameric complexes.

Authors:  Alexander F Kintzer; Katie L Thoren; Harry J Sterling; Ken C Dong; Geoffrey K Feld; Iok I Tang; Teri T Zhang; Evan R Williams; James M Berger; Bryan A Krantz
Journal:  J Mol Biol       Date:  2009-07-20       Impact factor: 5.469

8.  Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax.

Authors:  Sou-Ichi Makino; Masahisa Watarai; Hyeng-Il Cheun; Toshikazu Shirahata; Ikuo Uchida
Journal:  J Infect Dis       Date:  2002-06-27       Impact factor: 5.226

9.  Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging.

Authors:  Patrick Sanz; Louise D Teel; Farhang Alem; Humberto M Carvalho; Stephen C Darnell; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

10.  Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice.

Authors:  Mahtab Moayeri; Diana Haines; Howard A Young; Stephen H Leppla
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more
  30 in total

Review 1.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

2.  Gene expression profiling of primary human type I alveolar epithelial cells exposed to Bacillus anthracis spores reveals induction of neutrophil and monocyte chemokines.

Authors:  J Leland Booth; Elizabeth S Duggan; Vineet I Patel; Wenxin Wu; Dennis M Burian; David C Hutchings; Vicky L White; K Mark Coggeshall; Mikhail G Dozmorov; Jordan P Metcalf
Journal:  Microb Pathog       Date:  2018-04-25       Impact factor: 3.738

3.  Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.

Authors:  J Leland Booth; Elizabeth S Duggan; Vineet I Patel; Marybeth Langer; Wenxin Wu; Armin Braun; K Mark Coggeshall; Jordan P Metcalf
Journal:  Microbes Infect       Date:  2016-06-16       Impact factor: 2.700

4.  Development of a Zealand white rabbit deposition model to study inhalation anthrax.

Authors:  Bahman Asgharian; Owen Price; Senthil Kabilan; Richard E Jacob; Daniel R Einstein; Andrew P Kuprat; Richard A Corley
Journal:  Inhal Toxicol       Date:  2016       Impact factor: 2.724

5.  Treating Anthrax-Induced Meningitis in Rabbits.

Authors:  Amir Ben-Shmuel; Itai Glinert; Assa Sittner; Elad Bar-David; Josef Schlomovitz; Tal Brosh; David Kobiler; Shay Weiss; Haim Levy
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 6.  New insights into gastrointestinal anthrax infection.

Authors:  Jennifer L Owen; Tao Yang; Mansour Mohamadzadeh
Journal:  Trends Mol Med       Date:  2014-12-19       Impact factor: 11.951

7.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

8.  Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection.

Authors:  Tod J Merkel; Pin-Yu Perera; Gloria M Lee; Anita Verma; Toyoko Hiroi; Hiroyuki Yokote; Thomas A Waldmann; Liyanage P Perera
Journal:  Hum Vaccin Immunother       Date:  2013-06-20       Impact factor: 3.452

Review 9.  Bacillus anthracis factors for phagosomal escape.

Authors:  Fiorella Tonello; Irene Zornetta
Journal:  Toxins (Basel)       Date:  2012-07-10       Impact factor: 4.546

10.  Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.

Authors:  Bradford W Gutting; Tonya L Nichols; Stephen R Channel; Jeffery M Gearhart; George A Andrews; Alan E Berger; Ryan S Mackie; Brent J Watson; Sarah C Taft; Katie A Overheim; Robert L Sherwood
Journal:  Front Cell Infect Microbiol       Date:  2012-06-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.